Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

This is a a pilot study to assess the feasibility of intermittent caloric restriction (plus a plant-enriched diet optionally) in prostate cancer patients receiving androgen deprivation therapy. Study feasibility measures will include enrollment rate, drop-out rate and compliance with diet measured by self-reports.

Trial Details

NCT ID
NCT06172283
Phase
NA
Sponsor
State University of New York at Buffalo
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Intermittent Fasting
Locations (sample)
  • Buffalo, New York, United States|42.88645,-78.87837

Key Eligibility Criteria

  • In order to be eligible for participation in this trial, the subject must:
  • Be willing and able to provide written informed consent for the trial.
  • Be male at birth and least 18 years of age on day of signing informed consent.
  • Have measurable prostate cancer disease and be eligible for androgen deprivation therapy.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →